191 related articles for article (PubMed ID: 1390701)
1. Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats.
Abraham DJ; Wireko FC; Randad RS; Poyart C; Kister J; Bohn B; Liard JF; Kunert MP
Biochemistry; 1992 Sep; 31(38):9141-9. PubMed ID: 1390701
[TBL] [Abstract][Full Text] [Related]
2. Effect of an allosteric modifier of hemoglobin, RSR-4, on oxygen affinity and oxygen saturation of hemoglobin in rabbits.
Uchida K; Reilly MP; Abraham DJ; Asakura T
Jpn J Physiol; 1998 Dec; 48(6):439-44. PubMed ID: 10021497
[TBL] [Abstract][Full Text] [Related]
3. High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector.
Safo MK; Moure CM; Burnett JC; Joshi GS; Abraham DJ
Protein Sci; 2001 May; 10(5):951-7. PubMed ID: 11316875
[TBL] [Abstract][Full Text] [Related]
4. Synthesized allosteric effectors of the hemoglobin molecule: a possible mechanism for improved erythrocyte oxygen release capability in hemoglobinopathy H disease.
Papassotiriou I; Kister J; Griffon N; Abraham DJ; Kanavakis E; Traeger-Synodinos J; Stamoulakatou A; Marden MC; Poyart C
Exp Hematol; 1998 Sep; 26(10):922-6. PubMed ID: 9728926
[TBL] [Abstract][Full Text] [Related]
5. Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents.
Randad RS; Mahran MA; Mehanna AS; Abraham DJ
J Med Chem; 1991 Feb; 34(2):752-7. PubMed ID: 1995897
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors.
Wireko FC; Kellogg GE; Abraham DJ
J Med Chem; 1991 Feb; 34(2):758-67. PubMed ID: 1995898
[TBL] [Abstract][Full Text] [Related]
7. X-ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: compounds designed to link primary and secondary binding sites.
Safo MK; Boyiri T; Burnett JC; Danso-Danquah R; Moure CM; Joshi GS; Abraham DJ
Acta Crystallogr D Biol Crystallogr; 2002 Apr; 58(Pt 4):634-44. PubMed ID: 11914488
[TBL] [Abstract][Full Text] [Related]
8. New effectors of human hemoglobin: structure and function.
Lalezari I; Lalezari P; Poyart C; Marden M; Kister J; Bohn B; Fermi G; Perutz MF
Biochemistry; 1990 Feb; 29(6):1515-23. PubMed ID: 2334712
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and investigation of effects of 2-[4- [[(arylamino)carbonyl]amino]phenoxy]-2-methylpropionic acids on the affinity of hemoglobin for oxygen: structure-activity relationships.
Lalezari I; Lalezari P
J Med Chem; 1989 Oct; 32(10):2352-7. PubMed ID: 2795607
[TBL] [Abstract][Full Text] [Related]
10. Effects of the allosteric modification of hemoglobin on brain oxygen and infarct size in a feline model of stroke.
Watson JC; Doppenberg EM; Bullock MR; Zauner A; Rice MR; Abraham D; Young HF
Stroke; 1997 Aug; 28(8):1624-30. PubMed ID: 9259760
[TBL] [Abstract][Full Text] [Related]
11. X-ray diffraction study of di and tetra-ligated T-state hemoglobin from high salt crystals.
Abraham DJ; Peascoe RA; Randad RS; Panikker J
J Mol Biol; 1992 Sep; 227(2):480-92. PubMed ID: 1404365
[TBL] [Abstract][Full Text] [Related]
12. RSR-13, an allosteric effector of hemoglobin, increases systemic and iliac vascular resistance in rats.
Kunert MP; Liard JF; Abraham DJ
Am J Physiol; 1996 Aug; 271(2 Pt 2):H602-13. PubMed ID: 8770102
[TBL] [Abstract][Full Text] [Related]
13. Methyl acetyl phosphate as a covalent probe for anion-binding sites in human and bovine hemoglobins.
Ueno H; Pospischil MA; Manning JM
J Biol Chem; 1989 Jul; 264(21):12344-51. PubMed ID: 2745446
[TBL] [Abstract][Full Text] [Related]
14. Affinity labeling of hemoglobin with 4,4'-diisothiocyanostilbene-2,2'-disulfonate: covalent cross-linking in the 2,3-diphosphoglycerate binding site.
Kavanaugh MP; Shih DT; Jones RT
Biochemistry; 1988 Mar; 27(5):1804-8. PubMed ID: 3365425
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of chiral allosteric modifiers of hemoglobin.
Phelps Grella M; Danso-Danquah R; Safo MK; Joshi GS; Kister J; Marden M; Hoffman SJ; Abraham DJ
J Med Chem; 2000 Dec; 43(25):4726-37. PubMed ID: 11123981
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic activity at the molecular level: E. J. Ariëns' concept visualized.
Abraham DJ; Kister J; Joshi GS; Marden MC; Poyart C
J Mol Biol; 1995 May; 248(4):845-55. PubMed ID: 7752245
[TBL] [Abstract][Full Text] [Related]
17. T-quaternary structure of oxy human adult hemoglobin in the presence of two allosteric effectors, L35 and IHP.
Kanaori K; Tajiri Y; Tsuneshige A; Ishigami I; Ogura T; Tajima K; Neya S; Yonetani T
Biochim Biophys Acta; 2011 Oct; 1807(10):1253-61. PubMed ID: 21703224
[TBL] [Abstract][Full Text] [Related]
18. How allosteric effectors can bind to the same protein residue and produce opposite shifts in the allosteric equilibrium.
Abraham DJ; Safo MK; Boyiri T; Danso-Danquah RE; Kister J; Poyart C
Biochemistry; 1995 Nov; 34(46):15006-20. PubMed ID: 7578114
[TBL] [Abstract][Full Text] [Related]
19. Semihemoglobins, high oxygen affinity dimeric forms of human hemoglobin respond efficiently to allosteric effectors without forming tetramers.
Tsuneshige A; Kanaori K; Samuni U; Danstker D; Friedman JM; Neya S; Giangiacomo L; Yonetani T
J Biol Chem; 2004 Nov; 279(47):48959-67. PubMed ID: 15361521
[TBL] [Abstract][Full Text] [Related]
20. Bezafibrate derivatives as potent effectors of hemoglobin.
Poyart C; Marden MC; Kister J
Methods Enzymol; 1994; 232():496-513. PubMed ID: 8057877
[No Abstract] [Full Text] [Related]
[Next] [New Search]
